Identification of inhibitors of inducible nitric oxide synthase from microbial extracts

Journal of Antibiotics

Volumn 53, Issue 5, 2000, Pages 496-501

  Alvi, Khisal A ^a,b   Baker, Dwight D ^a,b   Stienecker, Vaughn ^a   Hosken, Margaret ^a   Nair, Bipin G ^a  

^a MDS Inc   (Canada)

^b ALBANY MOLECULAR RESEARCH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGUCYCLINE DERIVATIVE; ENZYME INHIBITOR; NITRIC OXIDE SYNTHASE; RABELOMYCIN; SAQUAYAMYCIN; UNCLASSIFIED DRUG; VINEOMYCIN C; XANTHOMEGNIN;

ANTIBIOTIC BIOSYNTHESIS; ARTICLE; CHEMICAL ANALYSIS; DRUG POTENCY; DRUG STRUCTURE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

STREPTOMYCES;

EID: 0034094916     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.53.496     Document Type: Article

References (18)

1. GROSS, S. S. & M. S. WOLIN: Nitric oxide: Pathophysiological mechanisms. Ann. Rev. Physiol. 57: 737-769, 1995
2. NATHAN, C.: Nitric oxide as a secretory product of mammalian cells. FASEB. J. 6: 3051-3064, 1992
3. DAWSON, T. W.; V. L. DAWSON & S. H. SYNDER: A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol. 32: 297-311, 1992
4. CHOI, D. W.: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634, 1988
5. MELDRUM, B. & J. GARTHWAITE: Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11: 379-387, 1990
6. UCHIDA, T.; M. IMOTO, Y. WATANABE, K. MIURA, T. DOBASHI, N. MATSUDA, T. SAWA, H. NAGANAWA, M. HAMADA, T. TAKEUCHI & H. UMEZAWA: Saquayamycins, new aquayamycin-group antibiotics. J. Antibiotic 38: 1171-1181, 1985
7. 1 with aquayamcin. Chem. Pharma. Bull. 29: 1788-1790, 1981
8. ALVI, K. A.; J. PETERSON & B. HOFMANN: Rapid identification of elaiophylin and geldanamycin in Streptomyces fermentation broths using CPC coupled with a photodiode array detector and LC-MS methodologies. J. Ind. Microbiol. 15: 80-84, 1995
9. STUEHR, D. J.; H. J. CHO, N. S. KWON, M. F. WEISE & C. F. NATHAN: Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD and FMN-containing flavoprotein. Proc. Natl. Acad. Sci. USA 88: 7773-7777, 1991
10. ALVI, K. A.; B. NAIR, H. PU, R. URSINO, C. GALLO & U. MOCEK: Phomacins: Three novel antitumor cytochalasan constituents produced by a Phoma sp. J. Org. Chem. 62: 2148-2151, 1997
11. Japanese Patient, 92:178379.
12. SEZAKI, M.; S. KONDO, K. MAEDA, H. UMEZAWA & M. OHNO: The structure of aquayamycin. Tetrahedron 26: 5171-5190, 1970
13. OHTA, A. K.; E. MIZUTA, H. OKAZAKI & T. KISHI: The absolute configuration of P-1894B, a potent prolyl hydroxylase inhibitor. Chem. Pharm. Bull. 32: 4350-4359, 1984
14. OHTA, K. & K. J. KAMIYA: X-Ray crystal structure of P-1894B, a collagen proline hydroxylase inhibitor produced by Streptomyces albogriseolus subsp. No. 1894. Chem. Soc. Chem. Commun. 1981: 154-155, 1981
15. SCOTT, A. I.: "Interpretation of the Ultra-violet Spectra of Natural Product." pp. 286-289, Pergamon Press, London, 1964
16. 1. J. Antibiotics 23: 602-608, 1982
17. COLE, R. J. & R. H. COX: In Handbook of Toxic Fungal Metabolites. pp. 815-816, Academic Press, New York, 1981
18. HIBBS, J. B. J.; Z. VAVRIN & R. R. TAINTOR: L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138: 550-565, 1987